4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (abbreviated NNK) is a nitrosamine present in tobacco that is a potent procarcinogen. It is activated by CYP2A6. It is a biomarker of exposure to cigarette smoke. It is produced upon the curing of tobacco.
